Enlaza Therapeutics Revenue

Biotechnology Research • San Diego, California, United States • 51-100 Employees

Enlaza Therapeutics revenue & valuation

Annual revenue	$5,000,000
Revenue per employee	$87,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$16,000,000
Total funding	$176,000,000

Key Contacts at Enlaza Therapeutics

Stephanie Pinkerton

Senior Director, Protein Therapeutics

Xiaolin Luo

Associate Director, Pharmacology

Dariusz T. Stepniak

Associate Director

Florian Sulzmaier

Director Of Pharmacology

Kevin Entzminger

Associate Director, Discovery

Denise Leatham

Director Of Operations

Yorke Zhang

Associate Director

Company overview

Headquarters	San Diego, California, United States
Phone number	+18587504700
Website	enlazatx.com
NAICS	541714
Keywords	Biotech, Oncology, Antibody Drug Conjugates, Covalent Biologics, Covalent Protein Drugs
Employees	51-100
Socials

Enlaza Therapeutics Email Formats

Enlaza Therapeutics uses 2 email formats. The most common is {first initial}{last name} (e.g., jdoe@enlazatx.com), used 75.4% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@enlazatx.com	75.4%
{first name}{last name}	johndoe@enlazatx.com	24.6%

About Enlaza Therapeutics

Enlaza Therapeutics is pioneering the field of covalent biologics. These novel classes of protein therapeutics deliver more efficacious and safer treatments for patients. The company’s proprietary War-Lock™ platform leverages leading synthetic biology technology for site-specific covalent coupling driven by drug binding. Enlaza is building a pipeline of first-in-class covalent biologics.

Employees by Management Level

Total employees: 51-100

Seniority

Employees

Entry

Senior

Director

Employees by Department

Enlaza Therapeutics has 14 employees across 7 departments.

Departments

Number of employees

Funding Data

Explore Enlaza Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount
2022-11-12	3	$61,000,000
2024-05-30	4	$100,000,000
2025-10-10	1	$15,000,000

Funding Insights

$176,000,000

Total funding amount

$15,000,000

Most recent funding amount

Number of funding rounds

Enlaza Therapeutics Tech Stack

Discover the technologies and tools that power Enlaza Therapeutics's digital infrastructure, from frameworks to analytics platforms.

MediaElement.js

Video players

reCAPTCHA

Security

Cloudflare Bot Management

Security

Gravity Forms

Form builders

ScrollMagic

JavaScript libraries

WP Rocket

Caching

Microsoft 365

jQuery Migrate

JavaScript libraries

Cloudflare

CDN

jQuery

JavaScript libraries

HTTP/3

Miscellaneous

PHP

Programming languages

Frequently asked questions

Enlaza Therapeutics is located in San Diego, California, US.

You can reach Enlaza Therapeutics at +18587504700.

Enlaza Therapeutics generates an estimated annual revenue of $5,000,000. This revenue figure reflects the company's market position and business performance in its industry.

Enlaza Therapeutics has an estimated valuation of $16,000,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Enlaza Therapeutics has approximately 51-100 employees. The company continues to grow its workforce to support its business operations and expansion.

Enlaza Therapeutics has raised a total of $176,000,000 across 3 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at Enlaza Therapeutics

Stephanie Pinkerton

Senior Director, Protein Therapeutics

Xiaolin Luo

Associate Director, Pharmacology

Dariusz T. Stepniak

Associate Director

Florian Sulzmaier

Director Of Pharmacology

Kevin Entzminger

Associate Director, Discovery

Denise Leatham